CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $18,049,000 | -1.2% | 728,385 | 0.0% | 0.39% | +35.0% |
Q1 2022 | $18,261,000 | -51.8% | 728,385 | -30.0% | 0.29% | -40.9% |
Q4 2021 | $37,866,000 | +112.9% | 1,040,000 | 0.0% | 0.48% | +106.0% |
Q3 2021 | $17,784,000 | -5.3% | 1,040,000 | -25.9% | 0.24% | -6.7% |
Q2 2021 | $18,786,000 | -34.5% | 1,403,000 | +150.5% | 0.25% | -40.7% |
Q1 2021 | $28,694,000 | +19.7% | 560,000 | +44.7% | 0.42% | +15.8% |
Q4 2020 | $23,963,000 | +47.2% | 387,000 | +30.3% | 0.37% | +15.0% |
Q3 2020 | $16,276,000 | +61.6% | 297,000 | +69.7% | 0.32% | +45.7% |
Q2 2020 | $10,069,000 | – | 175,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |